Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2000 Sep;55(9):789–794. doi: 10.1136/thorax.55.9.789

Recent trends in physician diagnosed COPD in women and men in the UK

J Soriano 1, W Maier 1, P Egger 1, G Visick 1, B Thakrar 1, J Sykes 1, N Pride 1
PMCID: PMC1745847  PMID: 10950900

Abstract

BACKGROUND—Recent trends in physician diagnosed chronic obstructive pulmonary disease (COPD) in the UK were estimated, with a particular focus on women.
METHODS—A retrospective cohort of British patients with COPD was constructed from the General Practice Research Database (GPRD), a large automated database of UK general practice data. Prevalence and all-cause mortality rates by sex, calendar year, and severity of COPD, based on treatment only, were estimated from January 1990 to December 1997.
RESULTS—A total of 50 714 incident COPD patients were studied, 23 277 (45.9%) of whom were women. From 1990 to 1997 the annual prevalence rates of physician diagnosed COPD in women rose continuously from 0.80% (95% CI 0.75 to 0.83) to 1.36% (95% CI 1.34 to 1.39), (p for trend <0.01), rising to the rate observed in men in 1990.Increases in the prevalence of COPD were observed in women of all ages; in contrast, a plateau was observed in the prevalence of COPD in men from the mid 1990s. All-cause mortality rates were higher in men than in women (106.8 versus 82.2 per 1000 person-years), with a consistently increased relative risk in men of 1.3 even after controlling for the severity of COPD. Significantly increased mortality rates were also observed in adults aged less than 65years. The mean age at death was 76.5 years; patients with severe COPD died an average of three years before those with mild disease (p<0.01) and four years before the age and sex matched reference population.
CONCLUSIONS—While prevalence rates of COPD in the UK seem to have peaked in men, they are continuing to rise in women. This trend, together with the ageing of the population and the long term cumulative effect of pack-years of smoking in women, is likely to increase the present burden of COPD in the UK.



Full Text

The Full Text of this article is available as a PDF (148.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Backhouse A., Holland W. W. Trends in mortality from chronic obstructive airways disease in the United Kingdom. Thorax. 1989 Jul;44(7):529–532. doi: 10.1136/thx.44.7.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crockett A. Screening older patients for obstructive airways disease. Thorax. 1999 Jun;54(6):472–473. doi: 10.1136/thx.54.6.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fabbri L., Caramori G., Beghe B., Papi A., Ciaccia A. Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med. 1998 Mar;4(2):76–84. doi: 10.1097/00063198-199803000-00004. [DOI] [PubMed] [Google Scholar]
  4. García Rodríguez L. A., Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998 May;45(5):419–425. doi: 10.1046/j.1365-2125.1998.00701.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hansell A., Hollowell J., Nichols T., McNiece R., Strachan D. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax. 1999 May;54(5):413–419. doi: 10.1136/thx.54.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jick H., Jick S. S., Derby L. E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991 Mar 30;302(6779):766–768. doi: 10.1136/bmj.302.6779.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kanner R. E., Connett J. E., Altose M. D., Buist A. S., Lee W. W., Tashkin D. P., Wise R. A. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med. 1994 Oct;150(4):956–961. doi: 10.1164/ajrccm.150.4.7921469. [DOI] [PubMed] [Google Scholar]
  8. Mannino D. M., Brown C., Giovino G. A. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):814–818. doi: 10.1164/ajrccm.156.3.9702026. [DOI] [PubMed] [Google Scholar]
  9. Nazareth I., King M., Haines A., Rangel L., Myers S. Accuracy of diagnosis of psychosis on general practice computer system. BMJ. 1993 Jul 3;307(6895):32–34. doi: 10.1136/bmj.307.6895.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Niu S. R., Yang G. H., Chen Z. M., Wang J. L., Wang G. H., He X. Z., Schoepff H., Boreham J., Pan H. C., Peto R. Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ. 1998 Nov 21;317(7170):1423–1424. doi: 10.1136/bmj.317.7170.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Parkin D. M., Muir C. S. Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ. 1992;(120):45–173. [PubMed] [Google Scholar]
  12. Peto R., Lopez A. D., Boreham J., Thun M., Heath C., Jr, Doll R. Mortality from smoking worldwide. Br Med Bull. 1996 Jan;52(1):12–21. doi: 10.1093/oxfordjournals.bmb.a011519. [DOI] [PubMed] [Google Scholar]
  13. Prescott E., Bjerg A. M., Andersen P. K., Lange P., Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997 Apr;10(4):822–827. [PubMed] [Google Scholar]
  14. Rawson N. S., Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med. 1995 Dec 30;14(24):2627–2643. doi: 10.1002/sim.4780142404. [DOI] [PubMed] [Google Scholar]
  15. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398–1420. doi: 10.1183/09031936.95.08081398. [DOI] [PubMed] [Google Scholar]
  16. Sunyer J., Antó J. M., McFarlane D., Domingo A., Tobías A., Barceló M. A., Múnoz A. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Sep;158(3):851–856. doi: 10.1164/ajrccm.158.3.9801093. [DOI] [PubMed] [Google Scholar]
  17. Thompson P. M., Wolf J. L. The sexual revolution in science: what gender-based research is telling us. J Investig Med. 1999 Mar;47(3):106–113. [PubMed] [Google Scholar]
  18. Traver G. A., Cline M. G., Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis. 1979 Jun;119(6):895–902. doi: 10.1164/arrd.1979.119.6.895. [DOI] [PubMed] [Google Scholar]
  19. van den Boom G., van Schayck C. P., van Möllen M. P., Tirimanna P. R., den Otter J. J., van Grunsven P. M., Buitendijk M. J., van Herwaarden C. L., van Weel C. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998 Dec;158(6):1730–1738. doi: 10.1164/ajrccm.158.6.9709003. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES